Atlas Trials

Depsipeptide (Romidepsin) in Treating Patients With Recurrent Ovarian Epithelial or Peritoneal Cavity Cancer

Clinical trial NCT00091195 · TERMINATED

Trial details

NCT number
NCT00091195
Sponsor
National Cancer Institute (NCI)
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Primary Peritoneal Cavity CancerRecurrent Ovarian Epithelial Cancer
Start date
2004-09-01
Primary completion
2007-03-01
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.